Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma
NCT07516392
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
1140
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma (mPDAC)
Interventions
OTHER:
Blood sample collection
Sponsor
Catholic University of the Sacred Heart